Scarica l'app Stockscreener
0.00
100.00%
-31.49
Dopo l'orario di chiusura:
31.48
31.48
+
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CPRX Giù?
Forum
Previsione
Catalyst Pharmaceuticals Inc Borsa (CPRX) Ultime notizie
Catalyst Pharmaceuticals stock leaves Nasdaq after USD 4.1 billion deal - AD HOC NEWS
Catalyst Pharmaceuticals (CPRX) Trades Flat at $31.49, Holding Inside a Well-Defined RangeWatchlist Stock Ideas - careplusvn.com
Catalyst Pharmaceutical Inc. (CPRX) Revenue 2025: $589.0M, up 19.8% - Stock Titan
Catalyst (CPRX) Quarter in Focus: Reported EPS Tops Expectations for the Current Session; Investor Response: Shares Show Little Net ChangeEarnings Seasonality - vinanet.vn
Catalyst Pharmaceuticals (CPRX) Holds Flat at $31.49 as Traders Eye $33.06 ResistanceLinear Regression - vinanet.vn
Chuck Royce's Second Quarter 2026 13F: Catalyst Pharmaceuticals Reduction Leads Portfolio Shifts - GuruFocus
Is Biohaven (BHVN)’s Latest Regeneron Pharmaceuticals (REGN) Deal a Major Catalyst for its Pipeline? - Yahoo Finance
Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: Navigating Stability with a 24.5% Return on Equity - DirectorsTalk Interviews
How Catalyst Pharmaceuticals Inc. (CPRX) Affects Rotational Strategy Timing - Stock Traders Daily
Catalyst Pharmaceuticals Inc (CPRX) Stock News Today - TradingKey
Catalyst Pharmaceuticals Inc (CPRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Rigel Pharmaceuticals: A Four-Drug Company With A Clinical Catalyst Ahead (NASDAQ:RIGL) - Seeking Alpha
Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: A Stable Outlook Amidst Consistent Valuation - DirectorsTalk Interviews
Catalyst Pharmaceuticals (CPRX) Holds Steady at $31.49: Key Support and Resistance Levels in FocusMarket Leader Picks - vinanet.vn
Catalyst Pharmaceuticals, Inc. Revenue Breakdown – LS:A0LCUL - TradingView
Catalyst Pharmaceuticals Inc (CPRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CPRX|Catalyst Pharmaceuticals Inc|Price:31.490| - TradingKey
Catalyst Pharmaceuticals Inc (CPRX) Cash Flow - TradingKey
TradingKey - TradingKey
CATALYST PHARMACEUTICALS, INC. SEC Filing (Jul 24, 2026) - Stock Titan
Catalyst Pharmaceuticals, Inc. $CPRX Stock Holdings Raised by Globeflex Capital L P - MarketBeat
Catalyst Pharmaceuticals | 8-K/A: Current report (Amendment) - Moomoo
Catalyst Pharmaceuticals stock steadies as investors weigh latest earnings momentum - AD HOC NEWS
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) leaves Nasdaq after cash reserves reduce deal multiple - TechStock²
Catalyst Pharmaceuticals (NASDAQ:CPRX) departs Nasdaq as merger spread narrows to one cent - TechStock²
Catalyst Pharmaceuticals CLO Brian Elsbernd Sells 242,501 Shares Amid Angelini Pharma Acquisition Completion - Kalkine Media
Catalyst Pharmaceuticals (CPRX) director’s RSUs and options cashed out in merger - Stock Titan
Catalyst Pharmaceuticals (NASDAQ: CPRX) HR chief equity cashed out at $31.50 - Stock Titan
Catalyst Pharmaceuticals (NASDAQ: CPRX) director equity converted to cash at $31.50 - Stock Titan
Angelini deal converts CATALYST PHARMACEUTICALS (NASDAQ: CPRX) officer equity to cash - Stock Titan
Catalyst Pharmaceuticals (CPRX) CCO exits equity in Angelini merger - Stock Titan
Catalyst Pharmaceuticals (CPRX) CEO equity converted to cash at $31.50 merger price - Stock Titan
Catalyst Pharmaceuticals (CPRX) CMO equity awards canceled for cash in Angelini merger - Stock Titan
Catalyst Pharmaceuticals (CPRX) CFO equity cancelled for cash in acquisition - Stock Titan
Catalyst Pharmaceuticals (CPRX) director’s RSUs and options cancelled in merger - Stock Titan
CATALYST PHARMACEUTICALS, INC. SEC Filing (Jul 17, 2026) - Stock Titan
CATALYST PHARMACEUTICALS, INC. SEC Filing (Jul 17, 2026) | CPRX EFFECT - Stock Titan
Catalyst Pharmaceuticals, Inc. Files 8-K: Merger Agreement Details, Corporate Information & XBRL Data (2026) - Minichart
Angelini Pharma completes $4.1 billion Catalyst acquisition By Investing.com - Investing.com Australia
Italy’s Angelini Pharma completes $4.1 billion state-backed takeover of Catalyst - 1470 & 100.3 WMBD
Italy's Angelini Pharma completes $4.1 billion state-backed takeover of Catalyst - Reuters
CATALYST PHARMACEUTICALS, INC. SEC Filing (Jul 15, 2026) - Stock Titan
Catalyst Pharmaceuticals Announced Transfer or Voluntary Withdrawal of Listing - TradingView
Angelini Pharma completes $4.1 billion Catalyst acquisition - Investing.com
Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals - NTB Kommunikasjon
Angelini wraps $4.1 billion buyout of Catalyst Pharmaceuticals (NASDAQ:CPRX) at 9x projected 2026 EBITDA - TechStock²
Nasdaq moves to delist Catalyst Pharmaceuticals (Nasdaq: CPRX) common stock - Stock Titan
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Shows Strong Growth and a High-Quality Technical Breakout Setup - ChartMill
Catalyst Pharmaceuticals, Inc.(NasdaqCM: CPRX) dropped from S&P 1000 - marketscreener.com
Catalyst Pharmaceuticals, Inc.(NasdaqCM: CPRX) dropped from S&P 600 Health Care - marketscreener.com
Catalyst Pharmaceuticals, Inc.(NasdaqCM: CPRX) dropped from S&P Composite 1500 - marketscreener.com
Catalyst Pharmaceuticals, Inc.(NasdaqCM: CPRX) dropped from S&P 600 - marketscreener.com
Catalyst Pharmaceuticals, Inc.(NasdaqCM:CPRX) dropped from S&P Biotechnology Select Industry Index - marketscreener.com
Catalyst Pharmaceuticals, Inc.(NasdaqCM: CPRX) dropped from S&P TMI Index - marketscreener.com
Catalyst Pharmaceuticals, Inc.(NasdaqCM: CPRX) dropped from S&P Global BMI Index - marketscreener.com
Angelini Pharma S.p.a. completed the acquisition of Catalyst Pharmaceuticals, Inc. from a group of shareholders. - marketscreener.com
Catalyst Pharmaceuticals (CPRX) Could Be 60% Undervalued As Merger Approval Reshapes The Board - Sahm
Catalyst Pharmaceuticals (CPRX) Holds Steady Near $31.50 Amid Sector ConsolidationWatchlist Stock Ideas - dars.gov.et
Catalyst Pharmaceuticals (CPRX) Holds Steady Near Support as Consolidation PersistsBearish Pattern Stocks - Bölüm Sonu Canavarı
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX): A Textbook GARP Stock Delivering Affordable Growth - ChartMill
Catalyst Pharmaceuticals Stockholders Clear Angelini Pharma Merger - Yahoo Finance
3.06%
2.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):